{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:58:27Z","timestamp":1790672307763,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["OPD-1511-33052"],"award-info":[{"award-number":["OPD-1511-33052"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"DOI":"10.1007\/s11606-026-10816-6","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:25:30Z","timestamp":1790623530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pain and Opioid Dose Reduction Based on Substance Use Disorder Status: Secondary Analysis from a Pragmatic Effectiveness Trial"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0106-5105","authenticated-orcid":false,"given":"Benjamin J.","family":"Morasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Hammett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth M.","family":"DeRonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis I.","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S. B.","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una E.","family":"Makris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob T.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Borsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildi J.","family":"Hagedorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"10816_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/10550490701862902","volume":"17","author":"JS Potter","year":"2008","unstructured":"Potter JS, Prather K, Weiss RD. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict. 2008;17:121-125.","journal-title":"Am J Addict."},{"key":"10816_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2017.03.006","volume":"77","author":"Y-I Hser","year":"2017","unstructured":"Hser Y-I, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Huang D. Chronic pain among patients with opioid use disorder: Results from electronic health records data. J Subst Abuse Treat. 2017;77:26-30.","journal-title":"J Subst Abuse Treat."},{"key":"10816_CR3","doi-asserted-by":"crossref","unstructured":"Nost TH, Skurtveit S, Odsbu I, Pederson L, Borchgrevink PC, Handal M. Prevalence of substance use disorder diagnoses in patients with chronic pain receiving reimbursed opioids: An epidemiologicaly study of four Norwegian health registries. Scan J Pain. 2024;24.","DOI":"10.1515\/sjpain-2024-0059"},{"key":"10816_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pain.2010.10.009","volume":"152","author":"BJ Morasco","year":"2011","unstructured":"Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, Dobscha SK. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain. 2011;152:488-497.","journal-title":"Pain."},{"key":"10816_CR5","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/add.13349","volume":"111","author":"MA Ilgen","year":"2016","unstructured":"Ilgen MA, Bohnert ASB, Chermack S, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111:1385-1393.","journal-title":"Addiction."},{"key":"10816_CR6","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamapsychiatry.2020.2369","volume":"77","author":"MA Ilgen","year":"2020","unstructured":"Ilgen MA, Coughlin LN, Bohnert ASB, et al. Efficacy of a psychosocial pain management intervention for men and women with substance use disorders and chronic pain: A randomized clinical trial. JAMA Psychiatry. 2020;77:1225-1234.","journal-title":"JAMA Psychiatry."},{"key":"10816_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamainternmed.2022.0033","volume":"182","author":"EL Garland","year":"2022","unstructured":"Garland EL, Hanley AW, Nakamura Y, et al. Mindfulness-oriented recovery enhancement vs supportive group therapy for co-occurring opioid misuse and chronic pain in primary care: A randomized clinical trial. JAMA Intern Med. 2022;182:407-417.","journal-title":"JAMA Intern Med."},{"key":"10816_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jpain.2010.07.010","volume":"12","author":"BJ Morasco","year":"2011","unstructured":"Morasco BJ, Corson K, Turk DC, Dobscha SK. Association between substance use disorder status and pain-related function following 12 months of treatment in primary care patients with musculoskeletal pain. J Pain. 2011;12:352-259.","journal-title":"J Pain."},{"key":"10816_CR9","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1111\/add.15401","volume":"116","author":"B Borsari","year":"2021","unstructured":"Borsari B, Li Y, Tighe J, et al. A pilot trial of collaborative care with motivational interviewing to reduce opioid risk and improve chronic pain management. Addiction 2021;116:2387-2397.","journal-title":"Addiction"},{"key":"10816_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jpain.2012.09.003","volume":"13","author":"AM Kobus","year":"2012","unstructured":"Kobus AM, Smith DH, Morasco BJ, et al. Correlates of high-dose opioid medication use for low back pain in primary care. J Pain. 2012;13:1131-1138.","journal-title":"J Pain."},{"key":"10816_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.pain.2010.08.002","volume":"151","author":"BJ Morasco","year":"2010","unstructured":"Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010; 151:625-632.","journal-title":"Pain."},{"key":"10816_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.pain.2009.05.006","volume":"145","author":"CM Weisner","year":"2009","unstructured":"Weisner CM, Campbell CI, Ray GT, et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 2009;145:287-293.","journal-title":"Pain"},{"key":"10816_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","volume":"162","author":"R Chou","year":"2015","unstructured":"Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of health Pathways to Prevention Workshop. Ann Int Med. 2015;162:276-286.","journal-title":"Ann Int Med."},{"key":"10816_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","volume":"156","author":"KE Vowles","year":"2015","unstructured":"Vowles KE, McEntee ML, Julnes PS, Frohe T, New JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain. 2015;156:569-576.","journal-title":"Pain."},{"key":"10816_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M17-0598","volume":"167","author":"JW Frank","year":"2017","unstructured":"Frank JW, Lovejoy TI, Becker WC, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: A systematic review. Ann Int Med. 2017;167:181-191.","journal-title":"Ann Int Med."},{"key":"10816_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.107001","volume":"124","author":"EE Krebs","year":"2023","unstructured":"Krebs EE, Becker WC, Nelson D, et al. Design, methods, and recruitment outcomes of the Veterans' Pain Care Organizational Improvement Comparative Effectiveness (VOICE) study. Contemp Clin Trials. 2023;124:107001. https:\/\/doi.org\/10.1016\/j.cct.2022.107001.","journal-title":"Contemp Clin Trials."},{"key":"10816_CR17","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s11606-019-05572-9","volume":"35","author":"KH Seal","year":"2020","unstructured":"Seal KH, Rife T, Li Y, Gibson C, Tighe J. Opioid Reduction and risk mitigation in VA primary care: Outcomes from the Integrated Pain Team Initiative. J Gen Int Med. 2020;35:1238-1244.","journal-title":"J Gen Int Med."},{"issue":"3","key":"10816_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jama.2014.7689","volume":"312","author":"K Kroenke","year":"2014","unstructured":"Kroenke K, Krebs EE, Wu J, Yu Z, Chumbler NR, Bair MJ. Telecare collaborative management of chronic pain in primary care: A randomized clinical trial. JAMA. 2014;312(3):240-8. https:\/\/doi.org\/10.1001\/jama.2014.7689.","journal-title":"JAMA."},{"key":"10816_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamainternmed.2024.6683","volume":"185","author":"EE Krebs","year":"2025","unstructured":"Krebs EE, Becker WC, Nelson D, et al. Care models to improve pain and reduce opioids among patients prescribed long-term opioid therapy: The VOICE randomized clinical trial. JAMA Intern Med. 2025;185:208-220.","journal-title":"JAMA Intern Med."},{"key":"10816_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/jamainternmed.2024.8361","volume":"185","author":"WC Becker","year":"2025","unstructured":"Becker WC, Seal KH, Nelson D, et al. Buprenorphine, pain, and opioid use in patients taking high-dose long-term opioids: A randomized clinical trial. JAMA Intern Med. 2025;185:372-381.","journal-title":"JAMA Intern Med."},{"key":"10816_CR21","doi-asserted-by":"publisher","unstructured":"Murray E, Charles C, Gafni A. Shared decision-making in primary care: tailoring the Charles et al. model to fit the context of general practice. Patient Educ Couns. 2006;62(2):205\u201311. https:\/\/doi.org\/10.1016\/j.pec.2005.07.003.","DOI":"10.1016\/j.pec.2005.07.003"},{"key":"10816_CR22","doi-asserted-by":"crossref","unstructured":"Bush K, Kivlahan DR, McDonnell MB, Fihn SD, Bradley KA, for the Ambulatory Care Quality Improvement Project. The AUDIT Alcohol Consumption Questions (AUDIT-C): An effective brief screening test for problem drinking. Arch Intern Med. 1998;158:1789\u20131795.","DOI":"10.1001\/archinte.158.16.1789"},{"key":"10816_CR23","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s11606-017-4079-x","volume":"32","author":"J Gryczynski","year":"2017","unstructured":"Gryczynski J, McNeely J, Wu LT, et al. Validation of the TAPS-1: A four-item screening tool to identify unhealthy substance use in primary care. J Gen Intern Med. 2017;32:990-996.","journal-title":"J Gen Intern Med."},{"issue":"4","key":"10816_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","volume":"32","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review. Gen Hosp Psychiatry. 2010;32(4):345-59.","journal-title":"Gen Hosp Psychiatry."},{"key":"10816_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00002508-200409000-00005","volume":"20","author":"S Keller","year":"2004","unstructured":"Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the Brief Pain Inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20:309-318.","journal-title":"Clin J Pain."},{"key":"10816_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","volume":"5","author":"G Tan","year":"2004","unstructured":"Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain. 2004;5:133-137.","journal-title":"J Pain."},{"key":"10816_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1007\/s11606-020-06339-3","volume":"36","author":"BA Howell","year":"2021","unstructured":"Howell BA, Abel EA, Park D, Edmond SN, Leisch LJ, Becker WC. Validity of incident opioid use disorder (OUD) diagnoses in administrative data: A chart verification study. J Gen Int Med. 2021;36:1264-1270.","journal-title":"J Gen Int Med."},{"key":"10816_CR28","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1097\/00002508-200207001-00004","volume":"18","author":"SR Savage","year":"2002","unstructured":"Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18:S28-S38.","journal-title":"Clin J Pain."},{"issue":"24","key":"10816_CR29","first-page":"00332","volume":"S1524\u20139042","author":"TI Lovejoy","year":"2025","unstructured":"Lovejoy TI, Wu TY, Maloy P, McPherson SM, Smith CL, Zaccari B. Collaborative tele-pain and substance use disorder care for patients in a rural setting: Results of a single-arm open-label pilot trial. Pain Manage Nurs. 2025;S1524-9042(24)00332-1.","journal-title":"Pain Manage Nurs."},{"key":"10816_CR30","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1007\/s11606-022-07476-7","volume":"37","author":"BJ Morasco","year":"2022","unstructured":"Morasco BJ, Adams MH, Hooker, ER, et al. A cluster-randomized clinical trial to decrease prescription opioid misuse: Improving the safety of opioid therapy (ISOT). J Gen Intern Med. 2022;37:3805-3813.","journal-title":"J Gen Intern Med."},{"key":"10816_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jama.2021.11013","volume":"326","author":"A Agnoli","year":"2021","unstructured":"Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 2021;326:411-419.","journal-title":"JAMA."},{"key":"10816_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/j.pain.0000000000002298","volume":"163","author":"SE Hallvik","year":"2022","unstructured":"Hallvik SE, El Ibrahimi S, Johnston K, et al. Patient outcomes after opioid dose reduction among patients with chronic opioid therapy. Pain. 2022;163:83-90.","journal-title":"Pain."},{"key":"10816_CR33","doi-asserted-by":"publisher","first-page":"e1004123","DOI":"10.1371\/journal.pmed.1004123","volume":"19","author":"MC Kennedy","year":"2022","unstructured":"Kennedy MC, Crabtree A, Nolan S, et al. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study. PLoS Med. 2022;19:e1004123.","journal-title":"PLoS Med."},{"key":"10816_CR34","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s11606-023-08459-y","volume":"39","author":"VE Metz","year":"2024","unstructured":"Metz VE, Ray GT, Palzes V, et al. Prescription opioid dose reductions and potential adverse events: A multi-site observational cohort study in diverse US health systems. J Gen Intern Med. 2024;39:1002-1009.","journal-title":"J Gen Intern Med."},{"key":"10816_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","volume":"103","author":"TL Mark","year":"2019","unstructured":"Mark TL, Parish W. Opioid medication discontinuation and risk of adverse opioid-related health care events. J Sub Abuse Treatment. 2019;103:58-63.","journal-title":"J Sub Abuse Treatment."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10816-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:02:34Z","timestamp":1790668954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10816-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":35,"alternative-id":["10816"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10816-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The VA Central Institutional Review Board approved the protocol. All participants signed informed consent to participate.","order":1,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Krebs received funding from the American College of Physicians Foundation for Opioid Response Efforts to attend a scientific meeting. No other author reports any potential conflict of interest.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}